ViewRay® Newsroom

 

ViewRay in the News

Simultaneous Tumor Tracking and Treatment Delivers Precise, Accurate Radiation

The Henry Ford Cancer Institute is the first in the world to offer patients an advanced radiation therapy that uses an FDA-approved real-time magnetic resonance imaging (MRI) to deliver more precise and accurate radiation treatment using a linear accelerator. With this new system, called ViewRay MRIdian Linac®, it is now possible to image the treatment area and deliver radiation at the same time -- more effectively protecting surrounding healthy tissue.

MRIdian Linac purchased by Institut du Cancer Montpellier (ICM).

Bringing the benefits of soft-tissue visualization and adaptive therapy to cancer patients throughout France.

ViewRay on Fox News

  Watch the ViewRay Segment

ViewRay on CNBC Power Lunch

  Watch the ViewRay Segment

MRIdian helps Paralympian Bibian Mentel win the Gold! Bibian recently overcame “untreatable” cancer following treatment with MRIdian at Vumc in the Netherlands.

  Watch the News Segment
Read more here

MRIdian is coming to UF Health Cancer Center, Orlando Health’s new comprehensive cancer center at Health Central Hospital in Ocoee, Florida.

Read about it here.

MRIdian Used to Treat Childhood Sarcoma at Washington University, St. Louis

Story featured on local news channels:

ViewRay’s Chris Raanes on Bloomberg-Radio

MRIdian Making Headlines in Dutch News

VUmc, Amsterdam and MRIdian have been featured on two Dutch news channels:

MRIdian Featured on ABC Los Angeles

MRIdian used to treat patient at UCLA - watch Lori’s story and interview with UCLA’s Dr. Percy Lee

MRI-Guided Radiotherapy: Two Years On

The first MRI-guided radiation treatment took place in January 2014, at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. The treatment was performed using ViewRay's MRIdian, which integrates a 0.35 T MRI with three gamma-emitting cobalt-60 sources.

SNNLive spoke with Chris A. Raanes, President and CEO of ViewRay, Inc. (OTCQB: VRAY) at the LD Micro "Main Event" 2015 in Bel Air, CA.

In this video interview, Mr. Raanes and our host discuss the following topics: Overview of ViewRay, Inc., Describes the company’s medical device, MRIdian®, Where the technology comes from and currently treating patients, Explains the process for approval process, and where they have been approved, Discusses various indications for the company’s device, Reimbursement, Mr. Raanes’ background, Growth drivers for ViewRay, Inc.

Groundbreaking Therapy Opens Window To See Cancerous Tumors In Motion

With the first MRI-guided radiotherapy system in the western U.S.— and one of only three locations in the world — UCLA radiation oncologists have an unparalleled ability to see and accurately target cancerous tumors, while making real-time adjustments to treatment delivery.
Beverly Hills Courier, November 2014

MRI-Guided Radiation Therapy

Precise adaptive radiation therapy guided by real-time MRI images could prove a significant advance in radiation oncology. Integrating those two tools is the driving force behind the MRIdian system, a combined real-time MRI and radiation therapy delivery process developed by Cleveland-based ViewRay.
Radiology Today, September 2014, Vol. 15 No. 9 P. 20

Visualizing Tumors During Treatment

A new technology called MRI-guided radiation therapy allows tumors to be visualized in real-time during treatment. In what has been called “a world’s first,” physicians at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis began treating patients with this new therapy in January 2014.
Radiation Oncology News for Administrators, June 2014

This article was originally published in Volume 24 No 2 of "Radiation Oncology News for Administrators" © 2014 The Society for Radiation Oncology Administrators (www.sroa.org). The Society for Radiation Oncology Administrators, the authority for radiation oncology operations, provides education, advocacy and information to radiation oncology administrators.  

Groundbreaking Therapy Opens Window To See Cancerous Tumors In Motion

With the first MRI-guided radiotherapy system in the western U.S.— and one of only three locations in the world — UCLA radiation oncologists have an unparalleled ability to see and accurately target cancerous tumors, while making real-time adjustments to treatment delivery.
Beverly Hills Courier, November 2014

MRI-Guided Radiation Therapy

Precise adaptive radiation therapy guided by real-time MRI images could prove a significant advance in radiation oncology. Integrating those two tools is the driving force behind the MRIdian system, a combined real-time MRI and radiation therapy delivery process developed by Cleveland-based ViewRay.
Radiology Today, September 2014, Vol. 15 No. 9 P. 20

Visualizing Tumors During Treatment

A new technology called MRI-guided radiation therapy allows tumors to be visualized in real-time during treatment. In what has been called “a world’s first,” physicians at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis began treating patients with this new therapy in January 2014.
Radiation Oncology News for Administrators, June 2014

This article was originally published in Volume 24 No 2 of "Radiation Oncology News for Administrators" © 2014 The Society for Radiation Oncology Administrators (www.sroa.org). The Society for Radiation Oncology Administrators, the authority for radiation oncology operations, provides education, advocacy and information to radiation oncology administrators.  

First MR-guided Radiation Treatment

The ViewRay MR-guided radiotherapy system has been used for the first time to perform real-time continuous MR imaging during a patient treatment. This breakthrough treatment took place on January 15 at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine (St Louis, MO), where the ViewRay system is now in regular clinical use.
Medical Physics Web, February 2014

ViewRay system gives new insight on MRI-guided therapy for patients

Cancer patients are receiving a significant boost in their treatment options as ViewRay’s (Cleveland) MRI-guided radiation therapy system is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine (St. Louis).
Medical Device Daily, February 2014

ViewRay MRI-Guided Radiation Therapy Used to Treat Cancer Patients

The ViewRay system, a MRI-guided radiation therapy system, is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Mo. The ViewRay system provides a combination of simultaneous radiation therapy delivery and continuous magnetic resonance imaging (MRI) for the treatment of cancer.
Imaging Technology News, February 2014

Breaking News: World’s only MRI-guided RT System Treats First Patients

The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri has started to treat patients using the ViewRayTM system, the world’s first and only real-time MRI-guided radiation therapy system.
The Advisory Board, February 2014

Interlinked Motion Control Key to MRI-Guided System

The collimators in the MRI-guided radiotherapy system require multiple components to shape gamma ray radiation therapy beams, and each has to be precisely controlled by one interlinked motion control system.
Medical Design, March 2013

A New View of Cancer Treatment

ViewRay's president believes the company's MRI machines will revolutionize radiation therapy. "I think this will change the way radiation oncology is practiced,” says Chris Raanes, ViewRay president and CEO. “Because once you've got the ability to see what you are doing in real time, how could you ever go back?”
Crain's Cleveland Business, March 2013

ViewRay Receives FDA Clearance for MRI-Guided Radiation Therapy System

By using real-time MRI, the ViewRay system shows soft tissue as it is being treated and adjusts for its movement in real time, without using any additional radiation.
medGadget, May 2012

ViewRay Secures Another $16 Million From Investors


ViewRay is well capitalized for its product launch, says CFO David Chandler, noting that the company has raised $45 million since 2010.
Crain's Cleveland Business, March 2012

ViewRay In the News Archive

Copyright 2016 © ViewRay. All rights reserved - KMCreative